Comparison of Bluejay Diagnostics (NASDAQ:BJDX) and STRATA Skin Sciences (NASDAQ:SSKN)
Bluejay Diagnostics (NASDAQ:BJDX – Get Rating) and STRATA Skin Sciences (NASDAQ:SSKN – Get Rating) are both small-cap medical companies, but which is the better company? We will compare the two companies based on the strength of their profitability, earnings, risk, dividends, analyst recommendations, institutional ownership and valuation.
This table compares the net margins, return on equity and return on assets of Bluejay Diagnostics and STRATA Skin Sciences.
|Net margins||Return on equity||return on assets|
|Diagnosis Bluejay||N / A||N / A||N / A|
|STRATA Skin Sciences||-8.85%||-18.46%||-10.18%|
Valuation and benefits
This table compares the revenue, earnings per share (EPS), and valuation of Bluejay Diagnostics and STRATA Skin Sciences.
|Gross revenue||Price/sales ratio||Net revenue||Earnings per share||Price/earnings ratio|
|Diagnosis Bluejay||N / A||N / A||-3.49 million dollars||N / A||N / A|
|STRATA Skin Sciences||$29.98 million||1.63||-$2.71 million||($0.08)||-17.63|
STRATA Skin Sciences has higher revenues and profits than Bluejay Diagnostics.
Institutional and Insider Ownership
46.3% of Bluejay Diagnostics shares are held by institutional investors. By comparison, 35.0% of STRATA Skin Sciences shares are held by institutional investors. 37.3% of the shares of STRATA Skin Sciences are held by insiders of the company. Strong institutional ownership is an indication that endowments, large fund managers, and hedge funds believe a company will outperform the market over the long term.
This is a summary of recent ratings and recommendations for Bluejay Diagnostics and STRATA Skin Sciences, as provided by MarketBeat.
|Sales Ratings||Hold odds||Buy reviews||Strong buy odds||Rating|
|STRATA Skin Sciences||0||0||0||0||N / A|
Bluejay Diagnostics currently has a consensus target price of $10.00, suggesting a potential upside of 949.32%. Considering the higher possible benefit of Bluejay Diagnostics, research analysts clearly believe that Bluejay Diagnostics is more favorable than STRATA Skin Sciences.
Bluejay Diagnostics beats STRATA Skin Sciences on 6 out of 9 factors compared between the two stocks.
Bluejay Diagnostics Company Profile (Get a rating)
Bluejay Diagnostics, Inc., a diagnostics company, develops and markets patient-directed products for the triage, diagnosis and monitoring of disease progression in the United States. It develops the Symphony Platform, a technology platform including the Symphony Fluorescence immunoanalyzer that orchestrates blood processing, biomarker isolation and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge Library, which includes reagents and components. The company also offers the ALLEREYE diagnostic test, a POC device for the diagnosis of allergic conjunctivitis. Furthermore, he is developing biomarkers for the detection of other diseases such as hsTNT/I for myocardial damage and NT-proBNP for heart failure. It has a license and supply agreement with Toray Industries, Inc. for the manufacture and distribution of protein detection chips. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.
Company Profile STRATA Skin Sciences (Get a rating)
STRATA Skin Sciences, Inc., a medical technology company, develops, markets and markets products for the treatment of skin conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa and in Central and South America. The Company operates through two segments, Dermatology Recurrent Procedures and Dermatology Procedures Equipment. Its products include the XTRAC excimer laser and VTRAC lamp systems which are used for the treatment of psoriasis, vitiligo, atopic dermatitis, eczema and other skin disorders. The company distributes its products internationally through distributors and domestically directly to physicians. The company was formerly known as MELA Sciences, Inc. and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.
Get news and reviews for Bluejay Diagnostics Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Bluejay Diagnostics and related companies with MarketBeat.com’s FREE daily newsletter.